Pablo García Jaén: rFVIIa Shows Promise for Secondary Prophylaxis in Glanzmann Thrombasthenia
Pablo García Jaén, Specialist in Hematology and Hemotherapy at Salamanca University Healthcare Complex (CAUSA), shared on LinkedIn about a recent article he and his colleagues co-authored, published in RPTH, adding:
”Very pleased to share our recently published Brief Report in Research and Practice in Thrombosis and Haemostasis:
‘Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia’
In this multicenter Spanish study, we describe the use of rFVIIa as secondary prophylaxis in patients with Glanzmann thrombasthenia and recurrent severe bleeding despite standard therapy.
We are proud to contribute to the limited evidence in this rare inherited platelet disorder and to share the first Spanish Brief Report focused on this field.
Many thanks to all participating centers, colleagues, patients and families, as well as GEAPC, RETPLAC and SETH, for making this collaborative work possible.”
Title: Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia
Authors: Pablo García-Jaén, Nuria Fernández-Mosteirin, María Luisa Serrano, Susana Riesco, Carlos Aguilar, David Gabaldon, Sara Kanaan-Leis, Almudena González-Prieto, Raquel Portugal, María Carmen Mendoza, Carmen Gilabert, Ana Hortal, Lorena Díaz-Ajenjo, Ana Lama-Villanueva, Alba Mei González-Galán, Ana Sánchez-Fuentes, Rocío Benito, José Rivera, José Ramón González-Porras, José María Bastida

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 16, 2026, 12:16Jeff Schaffnit: The Power of Community in Rare Blood Disorders
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada
-
Aug 16, 2026, 09:51Javier Amador-Castañeda: When a 32 Percent Reduction Tells Only Part of the Story
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?